MoneyWorks4Me

Ajanta Pharma board to consider Audited Financial Results

18 Apr 2013 Evaluate

Ajanta Pharma has informed that a meeting of the Board of Directors of the Company will be held on April 30, 2013, to consider and approve the Audited Financial Results for the year ended March 31, 2013 and recommending dividend, if any, on equity shares of the Company for the financial year 2012-13.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.00
View more..